Call Us 24x7

0536-5126876

The Development Tendency in Global Stem Cell Industry (Part One)

Latest news

The Development Tendency in Global Stem Cell Industry (Part One)

22/12/2019

Guide:The clinical application of stem cell medical technology was originated from 1968, when there appeared the first bone marrow transplantation in the world and treated a patient with severe combined immunodeficiency(SCID), which opened the door of application to stem cell in medicine. Currently, stem cells have been used to treat more than 140 diseases and are in clinical trials, and tens of thousands of stem cell transplants has been performed.

Global Stem Cell Therapy is Growing Rapidly,and Will Reach $400 Billion by 2020

The stem cell industry chain contains three parts: cell collection, preparation and storage in upstream, cell proliferation, cell differentiation and pharmaceutical preparation R&D in midstream and clinical treatment and application in downstream.The global stem cell industry chain has a steady growth in the upstream,but the most rapid development is in the downstream, which has entered a period of rapid development in clinical treatment.

The scale of global stem cell industry will continue to expand in the future. According to IMS, it will reach $400 billion by 2020. The basic research of China’s stem cell industry ranks the top of the world, with about 2,500 stem cell patents, ranking the second in the world. China’s stem cell industry started relatively late, but developed rapidly, and the scale is expected to reach 120 billion RMB by 2020.

Many Countries Speed Up Efforts to Accelerate Products Approval

Recent years, with the deepening of stem cell R&D around the world and the expansion of transform application, there are totally 16 stem cell drugs approved in global market now, among which the market applications of these drugs are most extensive in some areas in America, Japan and Europe countries. Stem cell technology has developed fast in recent years, it has great potential of clinical application in autoimmune disease,central nerve injury,CVD and other diseases. More than that, the advantages of stem cells therapies are obvious , such as safety, sufficient resources of therapeutic materials, wide range of therapeutic diseases and so on. Many countries regard it as one of the important research directions to develop.From the data that published so far,most of the clinical drugs that has been marketed for stem cells concentrated in European and American countries.

The leading development of market application of stem cell products in the United States is inseparable with the official research fund support from the United states government in recent years.According to the National Institutes of Health, the U.S. government’s official spending on stem cell research has been increasing since fiscal year 2015,and reached $1.824 billion in fiscal year 2018, an increase of 10.81% from the previous year. It is expected to rise to $1.912 billion in fiscal year 19.

China Constantly invigorated Policies to Support and Encourage Research and Applications in Stem Cell Industry

The research and applications of stem cell biology have become a vitally important part of life science.As national emphasis on stem cell medicine continues to rise, China’s policies on stem cells have been constantly strengthened.Compared with other countries, China has intensively published a number of development plans to support and guide the development of stem cell industry since 2017, such as The 13th Five-year Plan for the Development of Strategic Emerging Industries,The 13th Five-year Plan for Biotechnology Innovation and The 13th Five-year Plan for Technology Innovation of Health and Sanitation, which put forward clear direction and requirements in some aspects of stem cell industry such as development area, development measures and safeguard measures.

(From the Prospective Economist Application)